H.C. Wainwright & Co.
Tracked across 20 events · 138 articles · First seen Apr 01, 2026 · Last active Aug 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: H.C. Wainwright & Co. acted as the exclusive placement agent for Amesite's registered direct offering and concurrent private placement, facilitating the capital raise.
Apr 27, 2026 · 10 articles
Business
Impact: H.C. Wainwright & Co. acted as the exclusive placement agent for the private placement, facilitating the transaction for Bluejay Diagnostics.
Jun 02, 2026 · 10 articles
Business
Impact: H.C. Wainwright is hosting the 7th Annual Neuro Perspectives Expert Summit, providing a platform for companies like Gain Therapeutics to present to investors.
Jun 10, 2026 · 6 articles
Business
Impact: H.C. Wainwright & Co. served as a joint book-running manager, earning fees and reinforcing its presence in healthcare capital markets. The offering adds to its track record.
Aug 07, 2026 · 8 articles
Business
Impact: H.C. Wainwright & Co. is hosting the BioConnect Investor Conference where DBV Technologies will participate.
May 12, 2026 · 6 articles
Business
Impact: H.C. Wainwright & Co. is hosting the 7th Annual Neuro Perspectives Hybrid Conference, providing the venue for Lewis Pharmacy's participation.
Jun 01, 2026 · 7 articles
Business
Impact: H.C. Wainwright & Co. is hosting the 7th Annual Neuro Perspectives Expert Summit, where Immunic executives will present.
Jun 10, 2026 · 10 articles
Business
Impact: H.C. Wainwright & Co. is hosting its 28th Annual Global Investment Conference, where ZenaTech will present its company overview and growth strategy to institutional investors.
Jul 02, 2026 · 7 articles
Business
Impact: H.C. Wainwright & Co. acted as the exclusive placement agent for the offering, facilitating the transaction and earning placement agent fees.
Jul 10, 2026 · 6 articles
Business
Impact: H.C. Wainwright & Co. acts as the sales agent for Electra's ATM program, earning commissions on share sales.
Jul 06, 2026 · 7 articles
Business
Impact: Served as financial advisor to XOMA Royalty.
Jul 14, 2026 · 6 articles
Business
Impact: H.C. Wainwright & Co. reiterated a Buy rating on Vista Gold stock, maintaining a price target, indicating positive analyst sentiment towards the company.
Jun 08, 2026 · 7 articles
Business
Zymeworks Inc., a biotechnology company, announced that its management will participate in several upcoming investor conferences in September 2026. These include the Wells Fargo Healthcare Conference on September 8 in Boston, Citi's Biopharma Back to…
Impact: H.C. Wainwright is hosting an investment conference where Zymeworks will present. This is a routine event with no material impact on the firm.
Aug 11, 2026 · 6 articles
Business
Zentalis Pharmaceuticals, a clinical oncology company, announced the pricing of an underwritten public offering of 23 million shares of common stock at $3.50 per share, expecting gross proceeds of approximately $80.5 million. The offering is…
Impact: H.C. Wainwright acts as a passive bookrunner, earning underwriting fees.
Aug 13, 2026 · 6 articles
Business
Crexendo, Inc. announced on August 17, 2026 that its management team, including CEO Jeff Korn, President Doug Gaylor, and CFO Ron Vincent, will participate in three investor conferences in August and September 2026. The conferences…
Impact: H.C. Wainwright & Co. is hosting a conference where Crexendo will present, offering additional investor exposure.
Aug 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track H.C. Wainwright & Co. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard